HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of hemoperfusion using polymyxin B-immobilized fibers on acute lung injury in a rat sepsis model.

Abstract
Direct hemoperfusion using polymyxin B-immobilized column (PMX-DHP) is recognized as an effective treatment for septic shock. However, whether its efficacy is limited to cardiovascular dysfunction remains unknown. Therefore, we planned to examine the effects of PMX-DHP in an acute lung injury model. [Materials and methods] Rats were assigned to either PMX-DHP group or control group (n= 7 in each). A lung injury was created by the intratracheal instillation of LPS. In PMX-DHP group, an arteriovenous extracorporeal circuit using PMX column was applied for three hours. The same procedure using a dummy column was applied in control group. The lung microcirculation was observed, and adherent leukocytes, RBC velocity, and the arterial PaO2 were calculated. Pathological changes and the wet/dry weight ratio of the lungs were examined. [Results] Adherent leukocytes and platelets to the lung venules were recognized at 3 hours, and their numbers increased over time. Treatment with PMX-DHP significantly suppressed these events and helped maintenance of the blood flow and PaO2 levels. The lung edema and the histologic damages were also suppressed. [Conclusions] PMX-DHP improved the microcirculation by suppressing leukocyte and platelet adhesion. PMX-DHP had beneficial effects in a model for acute lung injury.
AuthorsToshiaki Iba, Isao Nagaoka, Atsushi Yamada, Masataka Nagayama, Takahiro Miki
JournalInternational journal of medical sciences (Int J Med Sci) Vol. 11 Issue 3 Pg. 255-61 ( 2014) ISSN: 1449-1907 [Electronic] Australia
PMID24516349 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Lipopolysaccharides
  • Polymyxin B
Topics
  • Acute Lung Injury (chemically induced, physiopathology, therapy)
  • Animals
  • Anti-Bacterial Agents (therapeutic use)
  • Disease Models, Animal
  • Erythrocytes (pathology)
  • Hemoperfusion
  • Humans
  • Leukocytes (pathology)
  • Lipopolysaccharides (toxicity)
  • Microcirculation (drug effects)
  • Platelet Adhesiveness (drug effects)
  • Polymyxin B (chemistry, therapeutic use)
  • Rats
  • Sepsis (chemically induced, physiopathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: